Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens

Gynecologic Oncology

Volumn 116, Issue 1, 2010, Pages 99-104

  Kim, Jo Heon ^a   Choi, Yoo Duk ^a   Lee, Ji Shin ^a   Lee, Jae Hyuk ^a   Nam, Jong Hee ^a   Choi, Chan ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Cervix; Cytology; Diagnosis; Methylation; Squamous cell carcinoma; Squamous intraepithelial lesion

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; GLUTATHIONE TRANSFERASE P1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; PROTEIN P16; PROTEIN TYROSINE PHOSPHATASE SHP 1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; TRANSCRIPTION FACTOR TWIST; UVOMORULIN;

ARTICLE; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; DNA METHYLATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; FEMALE; HUMANS; PROMOTER REGIONS, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 70749090028     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.09.032     Document Type: Article

References (29)

1. Shin H.R., Jung K.W., and Won Y.J. National cancer incidence for the year 2002 in Korea. Cancer Res. Treat. 39 (2007) 139-149
2. Pisani P., Bray F., and Parkin D.M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int. J. Cancer 97 (2002) 72-81
3. Nanda K., McCrory D.C., Myers E.R., et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann. Intern. Med. 132 (2000) 810-819
4. Kulasingam S.L., Hughes J.P., Kiviat N.B., et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 288 (2002) 1749-1757
5. Wajed S.A., Laird P.W., and DeMeester T.R. DNA methylation: an alternative pathway to cancer. Ann. Surg. 234 (2001) 10-20
6. Momparler R.L., and Bovenzi V. DNA methylation and cancer. J. Cell. Physiol. 183 (2000) 145-154
7. Belinsky S.A., Nikula K.J., Palmisano W.A., et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11891-11896
8. Laird P.W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3 (2003) 253-266
9. Lee J.S., Fackler M.J., Teo W.W., et al. Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis. Cancer Biol. Ther. 7 (2008) 1398-1406
10. Dong S.M., Kim H.S., Rha S.H., and Sidransky D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res. 7 (2001) 1982-1986
11. Virmani A.K., Muller C., Rathi A., Zoechbauer-Mueller S., Mathis M., and Gazdar A.F. Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res. 7 (2001) 584-589
12. Widschwendter A., Gattringer C., Ivarsson L., et al. Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin. Cancer Res. 10 (2004) 3396-3400
13. Gustafson K.S., Furth E.E., Heitjan D.F., Fansler Z.B., and Clark D.P. DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis. Cancer 102 (2004) 259-268
14. Reesink-Peters N., Wisman G.B., Jéronimo C., et al. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol. Cancer Res. 2 (2004) 289-295
15. Feng Q., Balasubramanian A., Hawes S.E., et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J. Natl. Cancer Inst. 97 (2005) 273-282
16. Wisman G.B., Nijhuis E.R., Hoque M.O., et al. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int. J. Cancer 119 (2006) 1908-1914
17. Shivapurkar N., Sherman M.E., Stastny V., et al. Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol. Oncol. 107 (2007) 549-553
18. Kahn S.L., Ronnett B.M., Gravitt P.E., and Gustafson K.S. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. Cancer 114 (2008) 57-64
19. Lai H.C., Lin Y.W., Huang T.H., et al. Identification of novel DNA methylation markers in cervical cancer. Int. J. Cancer 123 (2008) 161-167
20. Fackler M.J., Malone K., Zhang Z., et al. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin. Cancer Res. 12 (2006) 3306-3310
21. Palmisano W.A., Divine K.K., Saccomanno G., et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60 (2000) 5954-5958
22. Oka T., Ouchida M., Koyama M., et al. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Cancer Res. 62 (2002) 6390-6394
23. House M.G., Guo M., Iacobuzio-Donahue C., and Herman J.G. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis 24 (2003) 193-198
24. Bae Y.K., Brown A., Garrett E., et al. Hypermethylation in histologically distinct classes of breast cancer. Clin. Cancer Res. 10 (2004) 5998-6005
25. Fackler M.J., McVeigh M., Evron E., et al. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int. J. Cancer 107 (2003) 970-975
26. Nam J.H., Kim H.S., Lee J.S., Choi H.S., Min K.W., and Park C.S. A comparison of modified MonoPrep2 of liquid-based cytology with ThinPrep Pap test. Gynecol. Oncol. 94 (2004) 693-698
27. Schmitt F.C., Longatto-Filho A., Valent A., and Vielh P. Molecular techniques in cytopathology practice. J. Clin. Pathol. 61 (2008) 258-267
28. Wentzensen N., Sherman M.E., Schiffman M., and Wang S.S. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol. Oncol. 112 (2009) 293-299
29. Wu C., Sun M., Liu L., and Zhou G.W. The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 306 (2003) 1-12